Jiaxu Chen

22PUBLICATIONS
50CO-AUTHORS
Biomolecular modelling and designObstetrics and gynaecologyGeomatic engineering not elsewhere classifiedCardiology (incl. cardiovascular diseases)Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (22)

|Sep 28, 2026
Explore the Mechanism of Xiaoyaosan for Treatment of Bipolar Disorder Based on Network Pharmacology, Experimental Validation and Molecular Docking.

|Jul 11, 2026
Integrative Management of Premenstrual Dysphoric Disorder: The Role of Traditional Chinese Medicine.

|Jan 08, 2025
Correction: Qiu et al. Genistein Modified with 8-Prenyl Group Suppresses Osteoclast Activity Directly via Its Prototype but Not Metabolite by Gut Microbiota. Molecules 2022, 27, 7811.

Zuo-Cheng Qiu, Feng-Xiang Zhang, Xue-Ling Hu

|Dec 12, 2022
An RNA-targeting CRISPR-Cas13d system alleviates disease-related phenotypes in Huntington's disease models.

Kathryn H Morelli, Qian Wu, Maya L Gosztyla

|Nov 26, 2022
Genistein Modified with 8-Prenyl Group Suppresses Osteoclast Activity Directly via Its Prototype but Not Metabolite by Gut Microbiota.

Zuo-Cheng Qiu, Feng-Xiang Zhang, Xue-Ling Hu

|Nov 01, 2022
Nrf2 regulates the arginase 1+ microglia phenotype through the initiation of TREM2 transcription, ameliorating depression-like behavior in mice.

Lujuan He, Yi Zheng, Lixuan Huang

Pageof 4

Frequent Collaborators

3 joint publications

Kenji Hashimoto

3 joint publications

Qi Qi

3 joint publications

Qingyu Ma

3 joint publications

Ji-Chun Zhang